Patents by Inventor Gino Tutera

Gino Tutera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11972369
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Grant
    Filed: April 24, 2023
    Date of Patent: April 30, 2024
    Assignee: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Patent number: 11798659
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: October 24, 2023
    Assignee: The Sotto Pelle Group, LLC
    Inventor: Gino Tutera
  • Publication number: 20230259832
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Application
    Filed: April 24, 2023
    Publication date: August 17, 2023
    Applicant: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Patent number: 11727315
    Abstract: Systems and methods for providing a dosage on a device comprising an electronic circuit, an input device, and a display screen. The method includes receiving an input signal of a user indicating an input directed to a patient sex and patient status selected from the group comprising new patient, returning patient and booster patient. If the patient sex is female, an effective estradiol dosage and an effective testosterone dosage are determined using dosage calculation methods selected based on the patient status and additional female input parameters. If the patient sex is male an effective testosterone dosage is determined using dosage calculation methods selected based on the patient status and additional male input parameters.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: August 15, 2023
    Assignee: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Patent number: 11663529
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Grant
    Filed: May 3, 2022
    Date of Patent: May 30, 2023
    Assignee: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Publication number: 20220270732
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 25, 2022
    Applicant: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Patent number: 11393569
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: July 19, 2022
    Assignee: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Publication number: 20210375405
    Abstract: A computer-implemented method of providing a dosage and a transgender patient treatment lifecycle comprising receiving, by a computerized device, an input signal of a user indicating an input directed to a patient sex and a patient status, wherein the patient status is automatically determined by the processor and includes at least one of a new patient, a returning patient and a booster patient, determining by the processor at least one of an effective estradiol dosage and an effective testosterone dosage using dosage calculation methods selected based on the patient status, automated male-to-female input parameters or automated female-to-male input parameters, and male-to-female or female-to-male tracking parameters in response to receiving an input indicating that the patient sex is male-to-female or female-to-male, displaying on the display screen, the determined effective dosages, and administering a pellet comprising at least one of the determined effective dosages to the patient.
    Type: Application
    Filed: August 12, 2021
    Publication date: December 2, 2021
    Applicant: The SottoPelle Group, LLC
    Inventors: Gino Tutera, Stephen Nunn
  • Publication number: 20200388367
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Application
    Filed: February 24, 2020
    Publication date: December 10, 2020
    Applicant: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Publication number: 20200227153
    Abstract: Systems and methods for providing a dosage on a device comprising an electronic circuit, an input device, and a display screen. The method includes receiving an input signal of a user indicating an input directed to a patient sex and patient status selected from the group comprising new patient, returning patient and booster patient. If the patient sex is female, an effective estradiol dosage and an effective testosterone dosage are determined using dosage calculation methods selected based on the patient status and additional female input parameters. If the patient sex is male an effective testosterone dosage is determined using dosage calculation methods selected based on the patient status and additional male input parameters.
    Type: Application
    Filed: March 27, 2020
    Publication date: July 16, 2020
    Applicant: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Publication number: 20200219600
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Application
    Filed: February 24, 2020
    Publication date: July 9, 2020
    Applicant: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Patent number: 10642959
    Abstract: Systems and methods for providing a dosage on a device comprising an electronic circuit, an input device, and a display screen. The method includes receiving an input signal of a user indicating an input directed to a patient sex and patient status selected from the group comprising new patient, returning patient and booster patient. If the patient sex is female, an effective estradiol dosage and an effective testosterone dosage are determined using dosage calculation methods selected based on the patient status and additional female input parameters. If the patient sex is male an effective testosterone dosage is determined using dosage calculation methods selected based on the patient status and additional male input parameters.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: May 5, 2020
    Assignee: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Patent number: 10573409
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: February 25, 2020
    Assignee: The SottoPelle Group, LLP
    Inventor: Gino Tutera
  • Patent number: 10572628
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: February 25, 2020
    Assignee: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Publication number: 20190333617
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Application
    Filed: May 6, 2019
    Publication date: October 31, 2019
    Applicant: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Patent number: 10325075
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: June 18, 2019
    Assignee: The SottoPelle Group, LLC
    Inventor: Gino Tutera
  • Publication number: 20170091417
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Application
    Filed: March 11, 2015
    Publication date: March 30, 2017
    Applicant: THE SOTTOPELLE GROUP, LLC
    Inventor: Gino TUTERA
  • Publication number: 20170065805
    Abstract: Systems and methods for a trocar system including a trocar with a body portion defining a loading chamber, an ergonomically shaped handle portion, and an incising portion that defines a beveled tip. A lumen is formed through the body portion, the handle portion, and the incising portion. An obturator includes a tip, a shaft, and an obturator handle. The shaft is sized to be received within the lumen.
    Type: Application
    Filed: September 6, 2016
    Publication date: March 9, 2017
    Inventor: Gino TUTERA
  • Publication number: 20160292387
    Abstract: Systems and methods for providing a dosage on a device comprising an electronic circuit, an input device, and a display screen. The method includes receiving an input signal of a user indicating an input directed to a patient sex and patient status selected from the group comprising new patient, returning patient and booster patient. If the patient sex is female, an effective estradiol dosage and an effective testosterone dosage are determined using dosage calculation methods selected based on the patient status and additional female input parameters. If the patient sex is male an effective testosterone dosage is determined using dosage calculation methods selected based on the patient status and additional male input parameters.
    Type: Application
    Filed: June 7, 2016
    Publication date: October 6, 2016
    Inventor: Gino TUTERA
  • Publication number: 20160267252
    Abstract: A system and method for automatically calculating an accurate recommended dosage for hormone replacement therapy and automating the life cycle of a patient's treatment over time. The system and method can automatically acquire relevant patient parameters and apply a consistent formulaic approach to help reduce incorrect dosage determinations. A pellet insertion size may be determined and documented based on a calculated dosage, and an insertion side and lot numbers may be tracked and managed. In addition, corresponding revenues may be tracked and profitability may be reported for hormone replacement therapy practices.
    Type: Application
    Filed: May 25, 2016
    Publication date: September 15, 2016
    Inventor: Gino Tutera